ATCC - Development of Assays for Influenza (NEW CONTRACT IN FY24)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the development of assays for influenza and is a new initiative set to begin in fiscal year 2024, managed by the Centers for Disease Control and Prevention (CDC). This effort aims to enhance diagnostic tools and testing capabilities related to influenza, supporting public health and disease control measures. The contract is currently in the forecast phase, indicating that it is planned but not yet solicited or awarded. Key points include the CDC as the contracting agency and the involvement of designated points of contact for program and contracting matters, with Vic Veguilla serving as the program point of contact. Specific details regarding the solicitation number, location, type of set-aside, and NAICS code have not yet been provided. This contract underscores the CDC’s ongoing commitment to advancing influenza detection and response through improved assay development.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
